GB201613078D0 - Stem cells and cancer - Google Patents

Stem cells and cancer

Info

Publication number
GB201613078D0
GB201613078D0 GBGB1613078.3A GB201613078A GB201613078D0 GB 201613078 D0 GB201613078 D0 GB 201613078D0 GB 201613078 A GB201613078 A GB 201613078A GB 201613078 D0 GB201613078 D0 GB 201613078D0
Authority
GB
United Kingdom
Prior art keywords
cancer
stem cells
stem
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1613078.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1613078.3A priority Critical patent/GB201613078D0/en
Publication of GB201613078D0 publication Critical patent/GB201613078D0/en
Priority to EP17748898.8A priority patent/EP3491124A1/en
Priority to PCT/GB2017/052217 priority patent/WO2018020269A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/606—Transcription factors c-Myc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
GBGB1613078.3A 2016-07-28 2016-07-28 Stem cells and cancer Ceased GB201613078D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1613078.3A GB201613078D0 (en) 2016-07-28 2016-07-28 Stem cells and cancer
EP17748898.8A EP3491124A1 (en) 2016-07-28 2017-07-28 Stem cells and cancer
PCT/GB2017/052217 WO2018020269A1 (en) 2016-07-28 2017-07-28 Stem cells and cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1613078.3A GB201613078D0 (en) 2016-07-28 2016-07-28 Stem cells and cancer

Publications (1)

Publication Number Publication Date
GB201613078D0 true GB201613078D0 (en) 2016-09-14

Family

ID=56936745

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1613078.3A Ceased GB201613078D0 (en) 2016-07-28 2016-07-28 Stem cells and cancer

Country Status (3)

Country Link
EP (1) EP3491124A1 (en)
GB (1) GB201613078D0 (en)
WO (1) WO2018020269A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
CN105939767B (en) 2014-01-08 2018-04-06 弗洛设计声能学公司 Sound electrophoretic apparatus with alliteration electrophoresis chamber
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
CN112094804A (en) * 2019-06-18 2020-12-18 中国医学科学院基础医学研究所 Heterogeneous stem cell population, preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009151511A1 (en) * 2008-04-29 2009-12-17 Therasis, Inc. Systems and methods for identifying combinations of compounds of therapeutic interest
EP2675903A1 (en) * 2011-02-14 2013-12-25 University of Utah Research Foundation Constructs and methods for generating induced pluri potent stem ( ips) cells
US20140073519A1 (en) * 2011-03-03 2014-03-13 Cornell University Lung cancer-relevant human embryonic stem cell signature

Also Published As

Publication number Publication date
EP3491124A1 (en) 2019-06-05
WO2018020269A1 (en) 2018-02-01

Similar Documents

Publication Publication Date Title
HK1254190A1 (en) Universal donor stem cells and related methods
IL259586A (en) Genetically modified stem cells and uses thereof
GB201621889D0 (en) Cell
HK1255101A1 (en) Methods for obtaining regulatory t cells and uses thereof
GB201712733D0 (en) Methods & cells
GB201613078D0 (en) Stem cells and cancer
GB201616238D0 (en) Modified T cells
IL254412A0 (en) Prostate antigen standards and uses thereof
EP3202909A4 (en) Cancer specific-splicing ribozyme and use thereof
GB201603372D0 (en) Cell
SG11201701237QA (en) Compositions for modulating cancer stem cells and uses therefor
IL254156A0 (en) Methods for making neural stem cells and uses thereof
EP3420075A4 (en) Generation of cancer stem cells and use thereof
PL3586821T3 (en) Stem cell stimulating compositions and methods
GB201701509D0 (en) Pluripotenet stem cells
GB201612858D0 (en) New uses and methods
EP3299023A4 (en) Low-oxygen-treated mesenchymal stem cell and use thereof
GB2548839B (en) New uses and methods
GB201603311D0 (en) New uses and methods
ZA201900891B (en) B-cell-mimetic cells
EP3288570A4 (en) Modified stem cells and uses thereof
GB201805081D0 (en) Jet-effect and shaped tunnel
GB201609604D0 (en) Cell
GB201617716D0 (en) Cell
HK1257189A1 (en) Compositions and methods for inhibiting cancer stem cells

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)